Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (451-460 of 531) with videos related to

Pageof 54
Sort By:
Nature Communications|February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomasAaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potencyFranco Lori, R B Pollard, L Whitman, et al.
Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials GroupM N Levine, V H Bramwell, K I Pritchard, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Theory-based and Person-centered Approach to Design a Digital Tool for Improving Lifelong Congenital Heart Disease CareAnushree Agarwal, Joseph Valente, Karina Buenrostro, et al.
Cancer Research|April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCNChi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Genome Biology and Evolution|September 1, 2017
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in CambodiaChristian M Parobek, Jonathan B Parr, Nicholas F Brazeau, et al.
International Journal of Molecular Sciences|November 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven NeuroblastomaLei Zhai, Anushree Balachandran, Rebecca Larkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Pageof 54

Showing results (451-460 of 531) with videos related to

Sort By:
Pageof 54
Nature Communications|February 13, 2021
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomasAaminah Khan, Laura D Gamble, Dannielle H Upton, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potencyFranco Lori, R B Pollard, L Whitman, et al.
Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials GroupM N Levine, V H Bramwell, K I Pritchard, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Theory-based and Person-centered Approach to Design a Digital Tool for Improving Lifelong Congenital Heart Disease CareAnushree Agarwal, Joseph Valente, Karina Buenrostro, et al.
Cancer Research|April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCNChi Yan Ooi, Daniel R Carter, Bing Liu, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Genome Biology and Evolution|September 1, 2017
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in CambodiaChristian M Parobek, Jonathan B Parr, Nicholas F Brazeau, et al.
International Journal of Molecular Sciences|November 14, 2023
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven NeuroblastomaLei Zhai, Anushree Balachandran, Rebecca Larkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14Kathleen I Pritchard, Lois E Shepherd, Judith-Anne W Chapman, et al.
Pageof 54